Ari Maizel

Chief Commercial Officer

Ari Maizel (Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $1.4M of AXSM (7,500 sh × $184.44, as filed), executed Jan 21.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.8M

shares × price, as filed

Last traded

Apr 22

Filed Apr 23

Median ADV $188.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

AXSM

Axsome Therapeutics, Inc. AXSM · 0 buys · 2 sells 2 filings

Recent filings

AXSMSALE Axsome Therapeutics, Inc. View filing → $1.4M
7,500 sh × $182.42
Exec Apr 22
Filed Apr 23 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $1.4M
7,500 sh × $184.44
Exec Jan 21
Filed Jan 23 · 5:30 PM ET